Over 80 Companies Develop 100+ Pipeline Drugs for Alzheimer's Dementia
More than 80 companies are developing over 100 pipeline drugs targeting dementia associated with Alzheimer's disease. These innovative therapies include genetically targeted treatments and enhanced drug delivery systems, with many candidates in mid to late-stage clinical trials, highlighting promising market opportunities in this field.
Globenewswire_fr·


